Adimab, Mersana to combine antibody technologies
Adimab LLC (Lebanon, N.H.) and Mersana Therapeutics Inc. (Cambridge, Mass.) partnered to offer integrated access to Adimab's yeast-based antibody discovery technology and Mersana's antibody-drug conjugate (ADC) platform. Mersana's ADC platform consis..
Original Article: Adimab, Mersana to combine antibody technologiesNEXT ARTICLE